Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Vyne Therapeutics Inc (VYNE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Vyne Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.500 -0.070    -2.72%
11:26:07 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 15,894
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.430 - 2.500
Vyne Therapeutics 2.500 -0.070 -2.72%

NASDAQ:VYNE Financials

 
A brief overview of the NASDAQ:VYNE financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Vyne Therapeutics Inc over time.

VYNE Therapeutics Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 0.076 million compared to USD 0.006 million a year ago. Net loss was USD 6.19 million compared to USD 9.95 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 2.6 a year ago. Diluted loss per share from continuing operations was USD 0.2 compared to USD 2.6 a year ago. Basic loss per share was USD 0.2 compared to USD 3.33 a year ago. Diluted loss per share was USD 0.2 compared to USD 3.33 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

VYNE Income Statement

Gross margin TTM 100%
Operating margin TTM -6,900.47%
Net Profit margin TTM -6,710.38%
Return on Investment TTM -41.81%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 0.076 0.114 0.135 0.099
Gross Profit 0.076 0.114 0.135 0.099
Operating Income -6.83 -6.23 -10.32 -5.88
Net Income -6.19 -6.58 -10.06 -5.62

VYNE Balance Sheet

Quick Ratio MRQ 12.37
Current Ratio MRQ 12.73
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 0.24%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 97.68 19.27 24.96 35.26
Total Liabilities 8.95 7.76 7.69 8.83
Total Equity 88.74 11.5 17.27 26.43

VYNE Cash Flow Statement

Cash Flow/Share TTM -1.82
Revenue/Share TTM 0.03
Operating Cash Flow  -68.17%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -5.14 -5.15 -9.57 -5.48
Cash From Investing Activities -62.35 0 0 5
Cash From Financing Activities 82.66 -0.047 -0.005 -0.217
Net Change in Cash 15.17 -5.2 -9.58 -0.695
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VYNE Comments

Write your thoughts about Vyne Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
atamet kılıç
atamet kılıç Jan 13, 2023 4:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target 0,70
Mayona Maglanque Kirschner
Mayona Maglanque Kirschner Sep 14, 2022 2:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any referral to file a lawsuit against this company?
christian Knudsen
christian Knudsen May 11, 2022 9:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fraud Mangement worst ever.
christian Knudsen
christian Knudsen Apr 02, 2022 3:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ole Rii your comments reflect a 1 year fact zzzzzz fool
Ole Rii
Ole Rii Mar 04, 2022 1:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Get out quickly or be trapped for 2 or more years
Costas Socolis
Costas Socolis Mar 04, 2022 1:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
We are already trapped !
christian Knudsen
christian Knudsen Jan 14, 2022 10:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is in the process of spreading a lawsuit against the management for loss on a share split under false pretenses.
Costas Socolis
Costas Socolis Jan 13, 2022 2:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Game over
christian Knudsen
christian Knudsen Nov 11, 2021 9:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Worst Mangement ever.
christian Knudsen
christian Knudsen Oct 04, 2021 8:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stock 120 day and down 920% after revers stock split it is on the border to criminal wrong doing bye the Yvne Mangement.
christian Knudsen
christian Knudsen Oct 04, 2021 7:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mangement so pure so embarrassingly worst ever in the stock world...Steep down
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email